Hysteroscopic Assessment of Menopausal Breast-Cancer Patients Taking Tamoxifen; There is a Bias from the Mode of Endometrial Sampling in Estimating Endometrial Morbidity?

By Garuti Giancarlo   Grossi Francesco   Cellani Fulvia   Centinaio Giovanna   Colonnelli Monica   Luerti Massimo  

Breast Cancer Research and Treatment, Vol. 72, Iss. 3, 2002-04 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients

By Markovitch O.   Tepper R.   Fishman A.   Aviram R.   Cohen I.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Transvaginal Ultrasonographic Endometrial Follow-up in Postmenopausal Breast Cancer Patients with Tamoxifen Treatment

By Nahari C.   Tepper R.   Beyth Y.   Flex D.   Figer A.   Cohen I.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 222-226

Elsevier

Access to resources Recommend Favorite

Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer - pathological findings from NSABP protocol B-06

By Voogd A.C.   Peterse J.L.   Crommelin M.A.   Rutgers E.J.T.   Botke G.   Elkhuizen P.H.M.   van Geel A.N.   Hoekstra C.J.M.   van Pel R.   van de Vijver M.J.   Coebergh J.W.W.  

European Journal of Cancer, Vol. 35, Iss. 13, 1999-12 ,pp. : 1828-1837

Elsevier

Access to resources Recommend Favorite

Οutcomes for patients who are diagnosed with breast and endometrial cancer

By      

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 1103-1107

Spandidos Publications

Access to resources Recommend Favorite